Europe Aortic Valve Replacement Devices Market Forecast to 2030

Europe Aortic Valve Replacement Devices Market Forecast to 2030 – Regional Analysis – by Product (Sutureless Valve and Mechanical Valve), Surgery (Minimally Invasive Surgery and Open Surgery), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others).

Send Enquiry

$2,485$3,885

Description

The Europe aortic valve replacement devices market is expected to grow from US$ 1,812.09 million in 2022 to US$ 4,476.02 million by 2030. It is estimated to grow at a CAGR of 12.0% from 2022 to 2030.

Increasing Demand for Minimally Invasive Techniques Fuels Europe Aortic Valve Replacement Devices Market

The increasing demand for minimally invasive techniques in aortic valve replacement surgeries reflects a significant shift in medical practice and patient preferences. In a minimally invasive aortic valve replacement, a poorly working aortic valve is replaced with an artificial valve. This trend is driven by the desire to minimize the invasiveness of procedures, reduce the associated risks, and promote faster recovery times. Minimally invasive approaches typically involve smaller incisions and the use of specialized instruments and technologies to access the heart, which can lead to shorter hospital stays and less scarring. Moreover, patients often experience less pain and a quicker return to their daily activities. Surgeons have embraced these techniques due to their potential benefits, and advancements in medical devices and surgical skills have further facilitated widespread adoption. As a result, healthcare institutions are investing in training their medical teams and acquiring the necessary equipment to meet the increasing demand for minimally invasive aortic valve replacement surgeries, thereby providing patients with improved treatment options and enhanced overall healthcare experiences.

Europe Aortic Valve Replacement Devices Market Overview

The Europe aortic valve replacement devices market is sub-segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The regional market growth is associated with such as prevalence of valvular diseases, such as aortic stenosis & aortic regurgitation and others along with the increasing preference for minimally invasive surgeries in the region.

Europe Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Aortic Valve Replacement Devices Market Segmentation

The Europe aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the Europe aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger Europe aortic valve replacement devices market share in 2022.

Based on surgery, the Europe aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger Europe aortic valve replacement devices market share in 2022.

Based on end user, the Europe aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest Europe aortic valve replacement devices market share in 2022.

Based on country, the Europe aortic valve replacement devices market has been categorized into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe aortic valve replacement devices market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Artivion Inc, JenaValve Technology Inc, and Venus MedTech HangZhou Inc, are some of the leading companies operating in the Europe aortic valve replacement devices.

Summary Info

Industry:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 12.0% CAGR, the Europe Aortic Valve Replacement Devices Market is Speculated to be Worth US$ 4,476.02 million by 2030, says The Research Team’

According to The Research Team’ research, the Europe aortic valve replacement devices market was valued at US$ 1,812.09 million in 2022 and is expected to reach US$ 4,476.02 million by 2030, registering a CAGR of 12.0% from 2022 to 2030. Rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques are among the critical factors attributed to the Europe aortic valve replacement devices market expansion.

The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

• In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company’s extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.

• In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.

• In August 2021, CORCYM enrolled the first patient in the mitral, aortic, and tricuspid post-market study in a real-world setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve.

• In September 2020, Boston Scientific Corporation introduced the ACURATE neo2 aortic valve system in Europe. This next-generation TAVI technology—a new platform designed with multiple features to improve the clinical performance of the original ACURATE neo platform—had an expanded indication for patients with aortic stenosis compared to the aortic valve system of the previous generation.

Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.

On the contrary, product recalls hurdle the growth of Europe aortic valve replacement devices market.

Based on product, the Europe aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve segment held 63.1% share of Europe aortic valve replacement devices market in 2022, amassing US$ 1,143.18 million. It is projected to garner US$ 2,916.92 million by 2030 to expand at 12.4% CAGR during 2022–2030.

Based on surgery, the Europe aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held 83.6% share of Europe aortic valve replacement devices in 2022, amassing US$ 1,514.20 million. It is projected to garner US$ 3,876.62 million by 2030 to expand at 12.5% CAGR during 2022–2030.

Based on end user, the Europe aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held 64.2% share of Europe aortic valve replacement devices market in 2022, amassing US$ 1,163.73 million. It is projected to garner US$ 2,969.13 million by 2030 to expand at 12.4% CAGR during 2022–2030.

Based on country, the Europe aortic valve replacement devices market has been categorized into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe aortic valve replacement devices market in 2022. It was assessed at US$ 540.91 million in 2022 and is likely to hit US$ 1,416.66 million by 2030, exhibiting a CAGR of 12.8% during 2022–2030.

Key players operating in the Europe aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Artivion Inc, JenaValve Technology Inc, and Venus MedTech HangZhou Inc, among others.

In May 2023, Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low structural valve deterioration (SVD) rates in bioprosthetic aortic valves with the company’s innovative RESILIA tissue. The data, representing the longest clinical follow-up for Edwards’ bioprosthetic surgical aortic valve with RESILIA tissue with a mean follow-up of 7.7 years, were presented at the 103rd annual meeting of the American Association for Thoracic Surgery. In Feb 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe aortic valve replacement devices market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Europe aortic valve replacement devices market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the aortic valve replacement devices market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Aortic Valve Replacement Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. Europe Aortic Valve Replacement Devices Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Number of Aortic Valve Replacement Surgeries
5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:
6. Aortic Valve Replacement Devices Market – Europe Market Analysis
6.1 Europe Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
7. Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Europe Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
7.3.1 Overview
7.3.2 Mechanical Valve: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
7.4.1 Overview
7.4.2 Sutureless Valve: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Surgery.
8.1 Overview
8.2 Europe Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
8.3.1 Overview
8.3.2 Open Surgery: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
8.4.1 Overview
8.4.2 Minimally Invasive Surgery: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by End User.
9.1 Overview
9.2 Europe Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Aortic Valve Replacement Devices Market – Country Analysis
10.1 Europe Aortic Valve Replacement Devices Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Europe Aortic Valve Replacement Devices Market by Country
10.1.2.1 Germany
10.1.2.1.1 Overview
10.1.2.1.2 Germany: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 Germany: Aortic Valve Replacement Devices Market, by Product
10.1.2.1.4 Germany: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.1.5 Germany: Aortic Valve Replacement Devices Market, by End-User
10.1.2.2 UK
10.1.2.2.1 Overview
10.1.2.2.2 UK: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 UK: Aortic Valve Replacement Devices Market, by Product
10.1.2.2.4 UK: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.2.5 UK: Aortic Valve Replacement Devices Market, by End-User
10.1.2.3 France
10.1.2.3.1 Overview
10.1.2.3.2 France: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 France: Aortic Valve Replacement Devices Market, by Product
10.1.2.3.4 France: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.3.5 France: Aortic Valve Replacement Devices Market, by End-User
10.1.2.4 Italy
10.1.2.4.1 Overview
10.1.2.4.2 Italy: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Italy: Aortic Valve Replacement Devices Market, by Product
10.1.2.4.4 Italy: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.4.5 Italy: Aortic Valve Replacement Devices Market, by End-User
10.1.2.5 Spain
10.1.2.5.1 Overview
10.1.2.5.2 Spain: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 Spain: Aortic Valve Replacement Devices Market, by Product
10.1.2.5.4 Spain: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.5.5 Spain: Aortic Valve Replacement Devices Market, by End-User
10.1.2.6 Rest of Europe
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Europe: Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Europe: Aortic Valve Replacement Devices Market, by Product
10.1.2.6.4 Rest of Europe: Aortic Valve Replacement Devices Market, by Surgery
10.1.2.6.5 Rest of Europe: Aortic Valve Replacement Devices Market, by End-User
11. Europe Aortic Valve Replacement Devices Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in Europe Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Artivion Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 JenaValve Technology Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Venus MedTech HangZhou Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Aortic Valve Replacement Devices Market Segmentation
Table 2. Germany: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 3. Germany: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 4. Germany: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 5. UK: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 6. UK: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 7. UK: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 8. France: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 9. France: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 10. France: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 11. Italy: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 12. Italy: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 13. Italy: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 14. Spain: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 15. Spain: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 16. Spain: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 17. Rest of Europe: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Product
Table 18. Rest of Europe: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – Surgery
Table 19. Rest of Europe: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 20. Recent Organic Growth Strategies in Aortic Valve Replacement Devices Market
Table 21. Recent Inorganic Growth Strategies in the Aortic Valve Replacement Devices Market
Table 22. Glossary of Terms, Aortic Valve Replacement Devices Market

LIST OF FIGURES

Figure 1. Europe Aortic Valve Replacement Devices Market Segmentation, By Country
Figure 2. Europe – PEST Analysis
Figure 3. List of Vendors
Figure 4. Europe Aortic Valve Replacement Devices Market – Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
Figure 7. Europe Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Mechanical Valve: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Sutureless Valve: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Europe Aortic Valve Replacement Devices Market Revenue Share, by Surgery 2022 & 2030 (%)
Figure 11. Open Surgery: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Minimally Invasive Surgery: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Aortic Valve Replacement Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 14. Hospitals & Clinics: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ambulatory Surgery Centers: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Europe Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Aortic Valve Replacement Devices Market, By Country, 2022 (US$ Mn)
Figure 18. Europe Aortic Valve Replacement Devices Market, By Key Countries, 2022 And 2030 (%)
Figure 19. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 20. Germany: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 21. UK: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 22. France: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 23. Italy: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. Spain: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Rest of Europe: Aortic Valve Replacement Devices Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Growth Strategies in Europe Aortic Valve Replacement Devices Market

The List of Companies – Europe Aortic Valve Replacement Devices Market

o Abbott Laboratories
o Artivion Inc
o Boston Scientific Corp
o Edwards Lifesciences Corp
o JenaValve Technology Inc
o LivaNova Plc
o Medtronic Plc
o Venus MedTech HangZhou Inc

Reviews

There are no reviews yet.

Be the first to review “Europe Aortic Valve Replacement Devices Market Forecast to 2030”